IP Verse

Amorphous Kinase Inhibitor Formulations And Methods Of Use Thereof

Patent No. EP4084778 (titled "Amorphous Kinase Inhibitor Formulations And Methods Of Use Thereof") was filed by Deciphera Pharmaceuticals on Dec 30, 2020. The application was issued on Nov 1, 2023.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ALFRED E TIEFENBACHERAug 1, 2024HAMM & WITTKOPP

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP4084778

DECIPHERA PHARMACEUTICALS
Application Number
EP20845854A
Filing Date
Dec 30, 2020
Status
Granted And Under Opposition
Sep 29, 2023
Publication Date
Nov 1, 2023
External Links
Slate, Register , Google Patents